EARNINGS PER SHARE - Schedule of Basic and Diluted Earnings (Loss) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Jun. 26, 2023
Numerator:
Net income	$ 56,302	$ 114,403	$ 39,208	$ 38,823	$ 33,929	$ 30,275	$ 209,913	$ 103,027
Denominator:
Weighted average number of common shares outstanding (in shares)	178,826			181,884			179,956	180,829
Effect of dilutive securities (in shares)	1,702			1,138			1,330	931
Weighted average number of common shares outstanding, diluted (in shares)	180,528			183,022			181,286	181,760
Earnings per common share, basic
Earnings per common share, basic (in dollars per share)	$ 0.31			$ 0.21			$ 1.17	$ 0.57
Earnings per common share, diluted
Earnings per common share, diluted (in dollars per share)	$ 0.31			$ 0.21			$ 1.16	$ 0.57
Amedisys
Earnings per common share, diluted
Business combination, contingent consideration, asset, termination fee	$ 62,800						$ 62,800		$ 106,000